US equities
|
ANT
$95.30
▲+14.81%
NVDA
$147.34
▼-2.40%
AMD
$487.99
▼-7.95%
MU
$697.46
▼-1.11%
SPCX
$137.46
▼-4.21%
AMZN
$257.89
▼-3.68%
GOOGL
$273.86
▼-3.04%
SNDK
$763.66
▼-1.62%
ANT
$95.30
▲+14.81%
NVDA
$147.34
▼-2.40%
AMD
$487.99
▼-7.95%
MU
$697.46
▼-1.11%
SPCX
$137.46
▼-4.21%
AMZN
$257.89
▼-3.68%
GOOGL
$273.86
▼-3.04%
SNDK
$763.66
▼-1.62%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Jim Wilson
Recent news which mentions Jim Wilson
Center for Breakthrough Medicines signs $100M collaboration deal with Penn's gene therapy program
January 18, 2022
Tags
Biotech
Insurance
Joerg Ahlgrimm
From
Business Journals
Roseville wealth advisory firm Capital Planning Advisors acquired by growing Texas company
December 09, 2021
Tags
Jim Wilson
Capital Planning Advisors
Financial Planning
From
Business Journals
Amicus Therapeutics spins off genetic medicine unit in $600M SPAC deal
September 29, 2021
Tags
Health Care
Amicus Therapeutics
Jim Wilson
From
Business Journals